- NASDAQ:KTWO +26% on being acquired by Stryker.
- TRPX +21% on no significant event.
- NTIP +15% on patent ruling.
- SIG +14% on Q2 result.
- TLYS +14% on Q2 result.
- CIEN +9% on Q2 result.
- ZYNE +9% on its lead candidate ZYN002.
- GES +6% on Q2 result.
- CVM +6% on equity offering.
- INSY +6%. as FDA grants Fast Track designation for epinephrine nasal spray
- NNDM +5% on continuous Asia-Pacific expansion.
- GMS +5% on Q1 result.
- AMRS +5% as its zero-calorie sweetener made from sugarcane has received designation as GRAS by an independent expert panel.